HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Jacob Zeitani Selected Research
Jacob Zeitani Research Topics
Disease
2
Rupture
04/2020 - 10/2013
2
Aortic Dissection
09/2007 - 03/2006
1
Mitral Valve Insufficiency (Mitral Regurgitation)
12/2022
1
Inflammation (Inflammations)
01/2022
1
Acidosis
04/2020
1
Thoracoabdominal Aortic Aneurysm
04/2020
1
Carotid Artery Diseases
04/2015
1
Coronary Artery Disease (Coronary Atherosclerosis)
04/2015
1
Aortic Arch Aneurysm
10/2013
1
Aortic Valve Disease
08/2013
1
Atrial Fibrillation
08/2013
1
Endocarditis
07/2011
1
Death (Near-Death Experience)
07/2011
1
Thromboembolism
07/2011
1
Bone Fractures (Bone Fracture)
01/2008
1
Transient Ischemic Attack
11/2007
1
Hemorrhage
11/2007
1
Myocardial Infarction
11/2007
1
Stroke (Strokes)
11/2007
1
False Aneurysm (Pseudoaneurysm)
03/2006
1
Unstable Angina
03/2006
1
High Cardiac Output
06/2005
1
Surgical Wound Dehiscence
02/2004
1
Mediastinitis
02/2004
1
Wound Infection (Wound Infections)
02/2004
1
Wounds and Injuries (Trauma)
02/2004
Drug/Important Bio-Agent (IBA)
1
1,1'- (4,4,7,7- tetramethyl- 4,7- diazaundecamethylene)bis- 4- (3- methyl- 2,3- dihydro(benzo- 1,3- thiazole)- 2- methylidene)quinolinium (TOTO)
IBA
10/2013
1
Dihydrotachysterol (AT 10)
IBA
07/2011
Therapy/Procedure
3
Prostheses and Implants (Prosthesis)
04/2020 - 06/2005
3
Sternotomy
10/2013 - 02/2004
1
Myocardial Revascularization
12/2022
1
Euthanasia (Mercy Killing)
01/2022
1
Surgical Anastomosis
04/2020
1
Prosthesis Implantation
04/2020
1
Coronary Artery Bypass (Coronary Artery Bypass Surgery)
04/2015
1
Therapeutics
08/2013
1
Maze Procedure
08/2013
1
Aftercare (After-Treatment)
11/2007
1
Emergency Treatment
09/2007
1
Replantation
09/2007
1
Sutures (Suture)
03/2006
1
Debridement
02/2004
1
Contraindications
02/2004